In early July, I wrote to you about Chinook Therapeutics, Inc. (KDNY), a strong biotech stock that’s been on our Watchlist a few times. And I mentioned at the time that it had just become
As I write this on Friday morning, the Nasdaq is up roughly 2% for the week. The S&P 500 recorded four positive days in a row to start the week, and we are beginning to
Today, I want to revisit Chinook Therapeutics, Inc. (KDNY) and cover the latest move in the stock. Regular readers will know Chinook, as it was included on our Watchlist for the last two weeks… But
As I write this on Friday afternoon, the Nasdaq is down 5.6% for the week. As expected, the recent short-term bounce was a great opportunity to take a few short trades from better entry points.
Chinook Therapeutics, Inc. (Long Idea) I added Chinook Therapeutics, Inc. (KDNY) to the Watchlist last week, and it did not rise enough to hit our buy trigger. As I mentioned in the previous update, KDNY is
In Monday’s Watchlist Update, I explained that the new leaders of the current market environment seem to be biotechnology companies. Chemical, shipping and energy stocks had their run earlier this year, but as time went
It is vitally important to watch which stocks are making highs when the market is making lows. This is usually the next group of market leaders that can advance several hundred percent once the next
Chinook Therapeutics, Inc. (Long Idea) Chinook Therapeutics, Inc. (KDNY) is a biotech stock coming out of a two-year base pattern. Here’s how the chart is setting up… And here’s how the stock is setting up
Looking for an edge? Ross has the inside scoop on top analysis that will help grow your portfolio.. Receive a new stock opportunity every day and get ready to see your investment SURGE!
